Purdue Pharma’s $7.4 Billion Chapter 11 Plan Formally Approved

Start
A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from the Sackler family members who own Purdue and (2) a $900 million contribution from Purdue itself….
By: Knobbe Martens
Previous Story

[Podcast] The Data Stream – Episode 4 with Katherine Lowry

Next Story

FDA Approves Accord BioPharma’s Denosumab Biosimilars